We also detected the signature in some patients with KMT2A::MLLT1 or KMT2A::MLLT3 rearrangements (Fig. 6J; Supplementary Table 4), suggesting that the signature can be broadly applicable to KMT2A rearranged leukemia. This evidence concerns the gene MLLT3 and leukemia.